On the way in the door as the new CEO of Hologic ($HOLX), Stephen MacMillan said he would oversee further growth of the women's diagnostic medical imaging and surgical products company, despite Hologic's recent efforts to reorganize. With the guiding hand of Carl Icahn, who recently grabbed 12.6% of Hologic's shares, the M&A option was rumored to be on the table, but it looks as if the company will first aim to boost revenue if MacMillan, the former CEO of Stryker ($SYK), can make it happen. More from FierceDiagnostics